Nashville, TN - LBMC is proud to announce that Catrice James has been named as a top 30 Under 30 young professional by Cystic Fibrosis Foundation of Middle Tennessee. Nashville's Top 30 Under 30 recognizes the city's most active young professionals and philanthropists under the age of 30 who will be honored at a ceremony and silent auction benefiting the Cystic Fibrosis Foundation of Middle Tennessee's work to develop ways to control and cure cystic fibrosis.
Catrice James, Senior Tax Accountant, is heavily involved in the community. She was recently elected to serve on the Brentwood Family YMCA Board of Directors and is a volunteer soccer coach and basketball coach through the YMCA. She also serves as a mentor and tutor with Girls Inc. Catrice is a member of Young Leaders Council, serves on the TSCPA Young CPA Workgroup and is a CPA Ambassador for AICPA. Catrice earned her Bachelor's degree in Accountancy and International business from the University of Tennessee-Knoxville and her Master's degree from Middle Tennessee State University in Taxation Accounting. Catrice has been honored as NABA, Inc. National Scholar, NABA, Inc. Regional Scholar and earned a Haslam Business Scholarship.
Catrice and all 30 Under 30 recipients will be honored on Friday, April 10, 2015 at the Hutton Hotel in Nashville.
LBMC, PC, and The LBMC Family of Companies has over 400 employees, with offices in Chattanooga, Nashville (Brentwood), and Knoxville, Tenn. Founded in 1984 as a traditional accounting firm, LBMC has expanded its focus to meet a broad range of financial, human resources and technology needs for its diverse client base. Specific services offered by the LBMC "Family of Companies" include: accounting and assurance services, business and personal tax consulting, investment advisory services, professional staffing, human resources outsourcing, payroll services, technology solutions, IT security, healthcare consulting, planning services, litigation support, business valuations, and mergers and acquisitions. For more information, visit www.lbmc.com.
About the Cystic Fibrosis Foundation
Cystic fibrosis (CF) is a genetic disease that causes life-threatening lung infections and premature death, and affects about 70,000 people worldwide. The Cystic Fibrosis Foundation is the world's leader in the search for a cure for cystic fibrosis. The Foundation has fueled dramatic improvements in research and care that have significantly changed the prognosis for people with CF. Kalydeco, FDA-approved in 2012, is one of the biggest breakthroughs for the Foundation because it is the first to address the underlying cause of CF. The science behind Kalydeco has opened exciting new doors to research and development that may eventually lead to a cure for all people living with CF. Based in Bethesda, Md., the Foundation also supports and accredits a national care center network that has been recognized by the National Institutes of Health as a model of care for a chronic disease. Whereas most children with CF once died before reaching elementary school age, now people with CF live into their 30's and beyond. For more information about the Cystic Fibrosis Foundation, visit www.cff.org.